Ex-Date | Pay Date | Amount | Change |
---|---|---|---|
$0.3721 | |||
$0.3721 | 53.38% | ||
$0.6141 | 24.29% | ||
$0.2426 | -34.68% | ||
$0.3714 | 86.82% | ||
$0.4941 | 17.64% | ||
$0.42 | 11.41% | ||
$0.377 | 4.09% | ||
$0.3622 | 6.53% | ||
$0.34 | 33.86% | ||
$0.254 | -16.72% | ||
$0.305 | 33.07% | ||
$0.2292 |
Hikma Pharmaceuticals PLC pays a dividend yield (FWD) of 3.07%.
- ISIN
- WKN
- Symbol / Exchange
- / XLON
- Value
- €23.69
- Dividend frequency
- biannually
- Security Type
- Equity
- Sector
Health Care
- Country
United Kingdom
- Dividend Currency
- US Dollar
- Earnings Date
Similar securities
Those who hold Hikma Pharmaceuticals PLC often invest in these securities as well.
- Within the last 12 months, Hikma Pharmaceuticals PLC paid a dividend of $0.61. For the next 12 months, Hikma Pharmaceuticals PLC is expected to pay a dividend of $0.81. This corresponds to a dividend yield of approximately 3.07%.
- The dividend yield of Hikma Pharmaceuticals PLC is currently 3.07%.
- Hikma Pharmaceuticals PLC pays biannually dividends. This is paid in the months of September, May.
- The next dividend for Hikma Pharmaceuticals PLC is expected in September.
- Hikma Pharmaceuticals PLC paid dividend every year within the last 10 years.
- Dividends of $0.81 are expected for the next 12 months. This corresponds to a dividend yield of 3.07%.
- Hikma Pharmaceuticals PLC is assigned to the sector "Health Care".
- There are currently no known stock splits for Hikma Pharmaceuticals PLC.
- To receive the last dividend of Hikma Pharmaceuticals PLC on 1 May 2025 in the amount of $0.37 you had to have the stock in your portfolio before the ex-day on 20 March 2025.
- The last dividend was paid on 1 May 2025.
- In 2022, dividends of $0.42 were paid by Hikma Pharmaceuticals PLC.
- Dividends from Hikma Pharmaceuticals PLC are paid in US Dollar.
- The headquarters of Hikma Pharmaceuticals PLC is located in the United Kingdom.
- Further information on the amount and safety of the Hikma Pharmaceuticals PLC dividend can be found at Aktienfinder.